Multi-Cancer Screening: Benefits, Harms and Costs
Speaker:
Michael Astion, MD, PhD, Geoffrey Baird MD, PhDMichael Astion, MD, PhD, Geoffrey Baird MD, PhD, Creator and Co-Founder, PLUGS, Seattle Children’s Hospital, Professor, Department of Laboratory Medicine and Pathology, University of Washington; Professor and Chair, Department of Laboratory Medicine and Pathology, University of Washington
Contact Hours:
1.0
Date:
October 08, 2026 - October 31, 2027
Description:
Drs. Geoff Baird and Mike Astion discuss the current promises and pitfalls of MCED testing in the United States, including issues of cancer detection, overdiagnosis, costs, and insurance payments.
Learning Objectives:
- Describe the societal tradeoff in implementing wide scale population cancer screening for 50 cancers.
- List two downstream costs if the MCED screening test is positive.
- Explain the implications and requirements of the Nancy Gardner Sewell Law regarding payment for cancer screening by the government and insurance companies.
- Describe the opposing points of view regarding the results of the National Health Service clinical trial in the United Kingdom.